索拉非尼
医学
肝细胞癌
内科学
血管内皮生长因子
癌
血管内皮生长因子受体
肿瘤科
癌症研究
作者
Josep M. Llovet,Sergio Ricci,Vincenzo Mazzaferro,Philip Hilgard,Edward Gane,Jean Frédéric Blanc,André Cosme de Oliveira,Armando Santoro,Jean‐Luc Raoul,Alejandro Forner,Myron Schwartz,Camillo Porta,Stefan Zeuzem,Luigi Bolondi,Tim F. Greten,Peter R. Galle,Jean François Seitz,Ivan Borbath,Dieter Häussinger,Tom Giannaris
标识
DOI：10.1056/nejmoa0708857
摘要
In patients with advanced hepatocellular carcinoma, median survival and the time to radiologic progression were nearly 3 months longer for patients treated with sorafenib than for those given placebo. (ClinicalTrials.gov number, NCT00105443.)
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
浮游
shhoing
无极微光
Jared
NICAI
香蕉诗蕊
yznfly
gexzygg
子车茗
arizaki7
桃子
带头大哥
Zx_1993
xzy998
pluto
yyy
昏睡的蟠桃
eric888
star
求助人员
HaonanZhang
ceeray23
大龙哥886
Blitz
皖公网安备34019202002308
